SSPE: The Measles Aftershock That Arrives Years Later

Picture a campfire that looks completely out after a camping trip. The flames are gone and the logs are cold, so everyone heads home. Years later, a single hidden ember, buried deep in the ash, flickers back to life. That is a pretty good way to think about subacute sclerosing panencephalitis, or SSPE, a rare brain disease that can follow a measles infection long after the rash and fever are forgotten.
Most people think of measles as a bad week: high fever, a red blotchy rash, a cough, and watery eyes. For most kids, the immune system clears the virus and life goes on. But in a very small number of cases, the measles virus is not fully wiped out. Instead, it slips into the brain and goes quiet. Scientists have found that the virus in these cases is not quite the same as the original. It picks up changes, or mutations, in its genetic code, especially in a protein that helps it build and release new virus particles. Because of this, the virus can't spread normally from cell to cell the way regular measles does. Instead, it quietly passes directly from one brain cell to the next, hiding from the immune system while it does damage.
The wait is the creepy part. SSPE usually shows up about 7 to 10 years after the original measles infection, though it can appear sooner or much later. A child who got measles as a toddler might be a perfectly healthy second grader, then a fifth grader, and then something starts to feel off. Early signs are easy to miss or blame on something else. A student's grades slip, or their handwriting changes, or they seem forgetful, moody, or clumsy. Parents and teachers might assume it is stress or a rough patch.
As the disease moves forward, the symptoms become harder to ignore. People often develop sudden, jerky muscle movements called myoclonus, which look like brief, involuntary twitches or head drops. Seizures can follow, along with trouble walking, speaking, and seeing. Eventually, many patients lose the ability to move or respond to the world around them. The disease is progressive, meaning it keeps getting worse, and in most cases it is fatal, often within one to three years of the first symptoms. Some people decline much faster, and a few live longer, but overall the outlook is serious.
Doctors diagnose SSPE by putting several clues together. They look at the pattern of symptoms and at brain wave tests (EEGs), which often show a distinctive repeating pattern. They also test spinal fluid and blood for very high levels of measles antibodies, which is a strong sign that the immune system is still reacting to the virus long after the original infection. Brain imaging can help rule out other conditions.
Unfortunately, there is no cure. Some treatments, including antiviral drugs, an immune-boosting medicine called interferon, and an agent known as inosine pranobex, may slow the disease in some patients. But they are not a cure, and researchers are still looking for better options. Care also focuses on controlling seizures and keeping patients comfortable.
So how common is this? Overall, SSPE is rare. Older estimates put it at somewhere around 1 in 10,000 measles cases. But newer research suggests the risk is not the same for everyone. A study of measles cases in California found that children who caught measles before their first birthday faced a much higher risk, roughly 1 in 600. Babies are especially vulnerable because their immune systems are still developing, and they are too young to get the measles vaccine.
This is where the story turns hopeful. SSPE is one of the clearest examples of why vaccines matter beyond the immediate illness. The measles vaccine is highly effective, and two doses protect about 97 percent of people. Researchers have also found that SSPE is caused by wild measles virus, not by the vaccine strain, and that places with strong vaccination programs see far fewer cases. A baby too young for vaccination can't protect themselves, but they can be protected by the people around them. When enough people in a community are immune (usually about 95%), measles has a hard time finding its way to those babies. Scientists call this community immunity, or herd immunity.
It also helps to know that SSPE itself is not contagious. You can't catch it from someone who has it. The only way to get it is to have had measles first. That is exactly why preventing measles in the first place is the best defense we have.
The big takeaway is that some infections have long tails. A disease that looks like it is over can leave a hidden ember behind, and the best way to avoid that is to stop the fire from starting at all.
Sources
Bellini, W. J., Rota, J. S., Lowe, L. E., et al. (2005). Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than was previously recognized. The Journal of Infectious Diseases, 192(10), 1686–1693.
Centers for Disease Control and Prevention. (n.d.). Measles (Rubeola): For healthcare providers and clinical overview. cdc.gov
Garg, R. K. (2002). Subacute sclerosing panencephalitis. Postgraduate Medical Journal, 78(916), 63–70.
Gutierrez, J., Issacson, R. S., & Koppel, B. S. (2010). Subacute sclerosing panencephalitis: An update. Developmental Medicine & Child Neurology, 52(10), 901–907.
Wendorf, K. A., Winter, K., Zipprich, J., et al. (2017). Subacute sclerosing panencephalitis: The devastating measles complication that might be more common than previously estimated. Clinical Infectious Diseases, 65(2), 226–232.
World Health Organization. (n.d.). Measles: Fact sheet. who.int



Comments